Ji Xiang An
Chairman bij Changchun BCHT Pharmaceuticals Co. Ltd.
Actieve functies van Ji Xiang An
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Director/Board Member | 18-03-2014 | - |
Changchun BCHT Pharmaceuticals Co. Ltd. | Chairman | 22-01-2013 | - |
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Director/Board Member | 12-03-2014 | - |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Director/Board Member | 01-08-2013 | - |
Loopbaan van Ji Xiang An
Eerdere bekende functies van Ji Xiang An
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CHANGCHUN BCHT BIOTECHNOLOGY CO. | Chairman | 01-03-2004 | 09-07-2021 |
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Director/Board Member | 29-12-2014 | 23-06-2021 |
Chief Executive Officer | 26-06-2018 | 23-06-2021 | |
Corporate Officer/Principal | 29-12-2014 | - |
Statistieken
Internationaal
China | 7 |
Operationeel
Director/Board Member | 4 |
Chairman | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 6 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Health Technology |
CHANGCHUN BCHT BIOTECHNOLOGY CO. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Health Technology |
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Health Technology |
Changchun BCHT Pharmaceuticals Co. Ltd. | |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Health Technology |
- Beurs
- Insiders
- Ji Xiang An
- Ervaring